|View printer-friendly version|
|September 11, 2009 5:14 p.m.|
|Teva Announces Presentations at Bank Conferences|
|Jerusalem, Israel, September 11, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Morgan Stanley Global Healthcare Conference in New York with William Marth, President and Chief Executive Officer, Teva North America presenting on Monday, September 14, 2009. Eyal Desheh, Chief Financial Officer & Gerard van Odjik, President and CEO, Teva Europe will present on Tuesday, September 15, 2009 in London at the Bank of America Merrill Lynch Global Healthcare Conference. |
What: Teva Presentation at the Morgan Stanley Global Healthcare Conference
Teva Presentation at the Bank of America Merrill Lynch Global Healthcare Conference
Who: William Marth, President and Chief Executive Officer, Teva North America
Eyal Desheh, Chief Financial Officer
Gerard van Odjik, President & CEO, Teva Europe
When: Monday, September 14, 2009 at 9:45 a.m. ET Tuesday, September 15, 2009 at 1:00 p.m. UKT / 8:00 a.m. ET
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.